VEGFR2, Avi & His, Human
VEGFR2, Avi & His, Human

The purity of VEGFR2, Avi & His, Human is greater than 95% as determined by SEC-HPLC.

VEGFR2, Avi & His, Human

VEGFR2, Avi & His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

VEGFR2, Avi & His, Human

Immobilized VEGFR2, Avi & His, Human at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-VEGF R2 Antibody, hFc Tag with the EC50 of 5.2 ng/ml determined by ELISA.

VEGFR2, Avi & His, Human

The kinase insert domain receptor (KDR), also known as vascular endothelial growth factor receptor 2 (VEGFR-2), is a type IV receptor tyrosine kinase that plays a crucial role in various biological processes, including embryonic vasculature development, angiogenesis regulation, cell survival, migration, macrophage function, chemotaxis, and cancer cell invasion. It acts as a cell-surface receptor for VEGFA, VEGFB, and PGF. The human gene encoding KDR is also known as CD309 and Flk1 (Fetal Liver Kinase 1). VEGFR2 is a key regulator of angiogenesis.
Z03811
¥55,963.00

Ask us a question
Product Introduction
Species Human
Protein Construction
VEGFR2 (Ala20-Glu764)
Accession # P35968-1		 His tag Avi tag
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Endotoxin Level Less than 1 EU per μg by the LAL method.
Biological Activity Immobilized VEGFR2, Avi & His, Human (Cat.No.: Z03811) at 0.5 μg/ml can bind Anti­VEGFR2 Antibody.
Expression System HEK293
Theoretical Molecular Weight 86.2 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 115-140 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4.
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the lyophilized product remains stable up to 6 months at -20 °C or below as supplied from date of receipt.-80°C for 3 months after reconstitution.Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Examples
  • VEGFR2, Avi & His, Human
    • VEGFR2, Avi & His, Human

    The purity of VEGFR2, Avi & His, Human is greater than 95% as determined by SEC-HPLC.

  • VEGFR2, Avi & His, Human
    • VEGFR2, Avi & His, Human

    VEGFR2, Avi & His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

  • VEGFR2, Avi & His, Human
    • VEGFR2, Avi & His, Human

    Immobilized VEGFR2, Avi & His, Human at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-VEGF R2 Antibody, hFc Tag with the EC50 of 5.2 ng/ml determined by ELISA.


Background
Target Background The kinase insert domain receptor (KDR), also known as vascular endothelial growth factor receptor 2 (VEGFR-2), is a type IV receptor tyrosine kinase that plays a crucial role in various biological processes, including embryonic vasculature development, angiogenesis regulation, cell survival, migration, macrophage function, chemotaxis, and cancer cell invasion. It acts as a cell-surface receptor for VEGFA, VEGFB, and PGF. The human gene encoding KDR is also known as CD309 and Flk1 (Fetal Liver Kinase 1). VEGFR2 is a key regulator of angiogenesis.
Synonyms CD309; KDR; VEGFR; VEGFR2; VEGFR-21; FLK1; KRD1; Ly73

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.